
Apple AirPods Are Now FDA-Approved Hearing Aids — Here's What That Means
Apple's AirPods Pro 2 now officially double as hearing aids.
With FDA clearance granted late last year, the earbuds can be used as over-the-counter hearing devices for adults with mild to moderate hearing loss, marking a notable development in Apple's healthcare story.
The feature is rolling out to more countries this month, including Australia, Indonesia, Taiwan, and Vietnam, CEO Tim Cook confirmed in a July 15 post on X. In the same update, Apple expanded access to another health-oriented tool: sleep apnea detection for newer Apple Watch models.
The hearing aid function was first announced in 2024, alongside a suite of hearing health updates, and Apple at the time noted that it was still awaiting FDA clearance. That approval came in September, allowing the company to market the feature as an over-the-counter medical tool.
Unlike traditional hearing aids, which are often expensive and require in-person fittings, the AirPods Pro 2 update allows users to assess and manage their hearing through software alone. The process begins with a five-minute hearing test delivered via iPhone or iPad, which measures the user's ability to hear tones at varying frequencies. That data is then used to generate a custom hearing profile, stored in the iOS Health app, which automatically adjusts audio playback across calls, music, and other media.
Apple has also introduced a passive hearing protection mode that reduces exposure to loud environmental noise in real time — a feature the company says will remain always on.
The FDA cleared a new class of over-the-counter hearing aids in 2022 — the rule was designed to expand access to basic hearing care and lower costs, especially for adults with mild to moderate loss, a group the FDA estimates includes roughly 30 million Americans. While other companies including Bose and Eargo have launched OTC hearing aids since the rule took effect, Apple's entry arrives not through a medical device but via an update to an existing consumer product already owned by millions.
According to the World Health Organization, 1.5 billion people globally — nearly 20% of the population — live with some form of hearing loss, and the vast majority do not use hearing aids. That disconnect is often attributed to stigma, limited access, and cost — problems Apple is now attempting to address by integrating hearing assistance into mainstream, albeit also expensive, hardware.
This is definitely not Apple's first step into health tech, but it may be one of its more consequential ones: While features like heart-rate tracking and fall detection on the Apple Watch have been marketed as wellness tools, the new hearing and sleep offerings edge closer to medical-grade territory.
Meanwhile, the firm's sleep apnea detection tool, which uses wrist motion data to flag 'breathing disturbances' during sleep, also received clearance from the U.S. Food and Drug Administration — the feature is available on the Apple Watch Series 9, Series 10, and Ultra 2, and is now rolling out in over 150 countries.
Apple said the tool was trained and validated using a large clinical dataset and will analyze a user's breathing patterns over time to determine whether they show signs of moderate or severe sleep apnea. The results, categorized as 'elevated' or 'not elevated,' are viewable in the Health app, along with a report users can share with their physicians. According to Apple, the algorithm has been clinically validated and is intended to support, rather than replace, formal diagnosis or treatment.
Separately, Samsung also secured FDA clearance for its Galaxy Watch sleep apnea tracking last year.
As wearables increasingly take on functions once reserved for medical devices, the regulatory, ethical and consumer sentiment underpinning them may be ones to watch. Apple has so far walked a careful line, framing these tools as supplemental, useful for early detection or lifestyle awareness, but not total replacements for clinical care. In the case of the AirPods, the device now technically qualifies as a hearing aid under FDA rules, but its software-only setup also means that users are managing their own hearing support without audiologist involvement.
Whether this kind of DIY model will meet user needs as well as clinical standards is so far unknown, but perhaps it could alter expectations for what health tech looks like and, if embraced at scale, who its users are. For those who already own AirPods Pro 2, the update could offer a way to detect and manage early-stage hearing loss at no additional cost, and for Apple, it marks a push towards building medical capabilities into its most popular devices — whether or not the public views them as medical-grade tech, or simply smarter accessories.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
GitLab (GTLB) Stock: Why Wall Street Thinks AI Will Fuel Its Growth
GitLab Inc. (NASDAQ:) is one of the . On July 15, Rosenblatt initiated the stock as 'Buy' with a $58 price target. The firm said that the software company is well-positioned for growth and share gains. The technology landscape is witnessing increasing complexity in terms of application development, and there is a widespread adoption of AI-assisted coding. According to Rosenblatt, both of these factors are working in favour of GitLab. The firm contended that even though generative AI is commoditizing parts of the coding process, it will eventually lead to more code creation. This, according to Rosenblatt, benefits platforms like GitLab that manage the full software development lifecycle. A Wall Street trading floor, chaotic with activity as traders and financial analysts analyze the company's impact on the markets. The firm also pointed out that there is growth potential from selling its higher-tier 'Ultimate' plans and adopting new AI-based add-on products. Since there are only a quarter of GitLab's paying users currently on Ultimate, there is ample room to grow recurring revenue across its 10,000-plus customer base. 'In our view, the growth in and complexity of modern cloud and emerging GenAI applications and the upsell opportunity for GitLab provide significant runway for growth.' 'We believe GitLab has established itself as one of the two leading providers of comprehensive software development platforms, with over 30m registered users, and has broadened into many adjacent areas and additional personas, just in time to make the Company robust (and perhaps even anti-fragile) to the AI wave'. GitLab Inc. (NASDAQ:GTLB) develops software for the software development lifecycle in the US, Europe, and the Asia Pacific. While we acknowledge the potential of GTLB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo
10 minutes ago
- Yahoo
MikMak sees Potential for Advertising Clients on Netflix
Ahead of Netflix earnings, Rachel Tipograph, MikMak Founder & CEO, says Netflix is in its early days of tapping into the advertising business.
Yahoo
10 minutes ago
- Yahoo
MYOS PET and Leading Veterinarian Urge Action as Weather Extremes Impact Senior Pet Muscle Health
CEDAR KNOLLS, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- With climate changes becoming more severe, veterinary sports medicine and rehabilitation expert Dr. Kelly Fishman, DVM, CVA, CCRT, warns that summer heat waves and winter freezes are silently accelerating muscle loss in senior pets. But, MYOS PET, a science-based muscle health brand, is helping veterinarians address the issue with nutrition-based solutions like Fortetropin®. 'Just like humans, dogs and cats naturally lose muscle mass as they age,' said Fishman, founder of Strut Animal Mobility Specialists and veterinary advisory board member at MYOS PET. 'But aging isn't the only cause—extended periods of inactivity, especially when pets are kept indoors due to extreme heat or cold, can also accelerate muscle loss.' To help prevent weather-related muscle loss and take proactive steps to support muscle health year-round, Fishman encourages pet parents to adjust exercise routines based on seasonal conditions. During hot summer months, dogs should be walked in the early morning or late evening, when temperatures are cooler. Choosing shaded, grassy areas can help reduce overheating and protect sensitive paw pads. On especially hot days, low-impact activities like swimming in a pool or creating an indoor obstacle course can keep pets moving without risking heat stress. In colder months, Fishman says preparing your dog's body for movement is important. Gentle spine stretching before going outside can help warm up muscles and reduce the risk of injury. Creating a winter-friendly exercise plan using resistance bands or core-strengthening exercises on stability balls helps improve balance and maintain muscle health in all seasons, Fishman recommends incorporating MYOS PET into treatment plans for aging and recovering pets. MYOS PET contains Fortetropin, a natural bioactive compound derived from fertilized raw egg yolk that has been shown to support muscle protein synthesis and reduce muscle loss.'I recommend MYOS PET with Fortetropin for many of the dogs I rehab and I use it on my own senior cat to improve his energy and mobility,' said Fishman. 'Fortetropin is one of the few tools we have that's backed by credible research and helps preserve muscle through every season.' In studies, Fortetropin has demonstrated benefits for both dogs and cats, including increased lean muscle mass and improved recovery after orthopedic surgery, without adverse side effects. It is increasingly being used by veterinarians to support long-term mobility in senior, post-surgical, and sedentary pets. A study published in Frontiers in Veterinary Science involving working dogs found that a rigorous endurance training program, including treadmill running and obstacle courses, conducted during the winter and spring months not only enhanced the dogs' athletic performance, but also improved their ability to tolerate heat in the summer. Researchers observed that the trained dogs developed a kind of internal 'thermostat,' enabling their bodies to activate cooling mechanisms, such as panting, more efficiently and at lower temperatures. This helped keep them cooler and reduced the risk of heat-related stress during warmer conditions. Fishman says the findings suggest that staying active does more than just build muscle and strength, it can also condition a dog's body to better regulate temperature, ultimately improving performance and safety during periods of extreme heat. For more information on maintaining your pet's muscle health year-round visit Photos accompanying this announcement are available at CONTACT: Media Contact: Amy Summers 212-757-3419 | amy@ Pitch Publicity®Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data